As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR
Condition(s):Septic Shock; Sepsis, SevereLast Updated:July 7, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Septic Shock; Sepsis, SevereLast Updated:July 7, 2020Completed
Condition(s):Emergencies; Disease; In-hospital ObservationLast Updated:March 13, 2023Completed
Condition(s):PericarditisLast Updated:June 29, 2023Not yet recruiting
Condition(s):Triage; Risk Stratification With BiomarkerLast Updated:March 9, 2021Completed
Condition(s):SpondylodiscitisLast Updated:August 13, 2019Completed
Condition(s):Neonatal SepsisLast Updated:February 14, 2011Unknown status
Condition(s):Metabolic Disturbance; Periodontal DiseasesLast Updated:April 7, 2020Completed
Condition(s):Doxorubicin Adverse Reaction; Cardiomyopathies, Secondary; Breast CancerLast Updated:April 27, 2021Completed
Condition(s):Thoracic Surgery; Cardiac Surgical Procedures; BiomarkersLast Updated:March 3, 2020Completed
Condition(s):Critical IllnessLast Updated:February 11, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.